242 related articles for article (PubMed ID: 30408108)
21. Variants in the DRD2 locus and antipsychotic-related prolactin levels: A meta-analysis.
Miura I; Zhang JP; Hagi K; Lencz T; Kane JM; Yabe H; Malhotra AK; Correll CU
Psychoneuroendocrinology; 2016 Oct; 72():1-10. PubMed ID: 27333159
[TBL] [Abstract][Full Text] [Related]
22. Optimal extent of dopamine D2 receptor occupancy by antipsychotics for treatment of dopamine supersensitivity psychosis and late-onset psychosis.
Iyo M; Tadokoro S; Kanahara N; Hashimoto T; Niitsu T; Watanabe H; Hashimoto K
J Clin Psychopharmacol; 2013 Jun; 33(3):398-404. PubMed ID: 23609386
[TBL] [Abstract][Full Text] [Related]
23. Dopaminergic genes influence early response to atypical antipsychotics in patients with first presentation of psychosis.
Prata DP; Gafoor R; Kay V; Arranz M; Munro J; McGuire P
J Clin Psychopharmacol; 2012 Aug; 32(4):566-9. PubMed ID: 22760349
[No Abstract] [Full Text] [Related]
24. Preliminary evidence that negative symptom severity relates to multilocus genetic profile for dopamine signaling capacity and D2 receptor binding in healthy controls and in schizophrenia.
Eisenstein SA; Bogdan R; Chen L; Moerlein SM; Black KJ; Perlmutter JS; Hershey T; Barch DM
J Psychiatr Res; 2017 Mar; 86():9-17. PubMed ID: 27886638
[TBL] [Abstract][Full Text] [Related]
25. Dopamine receptor D2 and catechol-O-methyltransferase gene polymorphisms associated with anorexia nervosa in Chinese Han population: DRD2 and COMT gene polymorphisms were associated with AN.
Peng S; Yu S; Wang Q; Kang Q; Zhang Y; Zhang R; Jiang W; Qian Y; Zhang H; Zhang M; Xiao Z; Chen J
Neurosci Lett; 2016 Mar; 616():147-51. PubMed ID: 26808641
[TBL] [Abstract][Full Text] [Related]
26. Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.
Lafuente A; Bernardo M; Mas S; Crescenti A; Aparici M; Gasso P; Deulofeu R; Mane A; Catalan R; Carne X
Psychiatry Res; 2008 Nov; 161(2):131-41. PubMed ID: 18922583
[TBL] [Abstract][Full Text] [Related]
27. Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone.
Yamanouchi Y; Iwata N; Suzuki T; Kitajima T; Ikeda M; Ozaki N
Pharmacogenomics J; 2003; 3(6):356-61. PubMed ID: 14610521
[TBL] [Abstract][Full Text] [Related]
28. Catechol-O-methyltransferase rs4680 and rs4818 haplotype association with treatment response to olanzapine in patients with schizophrenia.
Nikolac Perkovic M; Sagud M; Zivkovic M; Uzun S; Nedic Erjavec G; Kozumplik O; Svob Strac D; Mimica N; Mihaljevic Peles A; Pivac N
Sci Rep; 2020 Jun; 10(1):10049. PubMed ID: 32572118
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes.
Mas S; Gassó P; Lafuente A; Bioque M; Lobo A; Gonzàlez-Pinto A; Olmeda MS; Corripio I; Llerena A; Cabrera B; Saiz-Ruiz J; Bernardo M;
Pharmacogenomics J; 2016 Oct; 16(5):439-45. PubMed ID: 27272046
[TBL] [Abstract][Full Text] [Related]
30. Interaction between childhood adversity and functional polymorphisms in the dopamine pathway on first-episode psychosis.
Trotta A; Iyegbe C; Yiend J; Dazzan P; David AS; Pariante C; Mondelli V; Colizzi M; Murray RM; Di Forti M; Fisher HL
Schizophr Res; 2019 Mar; 205():51-57. PubMed ID: 29653893
[TBL] [Abstract][Full Text] [Related]
31. Catechol-O-methyltransferase gene variants may associate with negative symptom response and plasma concentrations of prolactin in schizophrenia after amisulpride treatment.
Chen CY; Yeh YW; Kuo SC; Ho PS; Liang CS; Yen CH; Lu RB; Huang SY
Psychoneuroendocrinology; 2016 Mar; 65():67-75. PubMed ID: 26724569
[TBL] [Abstract][Full Text] [Related]
32. Association between dopamine receptor gene polymorphisms and effects of risperidone treatment: A systematic review and meta-analysis.
Ma L; Zhang X; Xiang Q; Zhou S; Zhao N; Xie Q; Zhao X; Zhou Y; Cui Y
Basic Clin Pharmacol Toxicol; 2019 Jan; 124(1):94-104. PubMed ID: 30103286
[TBL] [Abstract][Full Text] [Related]
33. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
[TBL] [Abstract][Full Text] [Related]
34. Dopamine supersensitivity psychosis and dopamine partial agonist: a retrospective survey of failure of switching to aripiprazole in schizophrenia.
Takase M; Kanahara N; Oda Y; Kimura H; Watanabe H; Iyo M
J Psychopharmacol; 2015 Apr; 29(4):383-9. PubMed ID: 25735995
[TBL] [Abstract][Full Text] [Related]
35. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment.
Molero P; Ortuño F; Zalacain M; Patiño-García A
Pharmacogenomics J; 2007 Dec; 7(6):418-26. PubMed ID: 17363961
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of clozapine on dopamine supersensitivity psychosis in schizophrenia.
Nakata Y; Kanahara N; Kimura H; Watanabe H; Iyo M
Int Clin Psychopharmacol; 2017 May; 32(3):169-173. PubMed ID: 28067751
[TBL] [Abstract][Full Text] [Related]
37. Association of DRD2, DRD4 and COMT genes variants and their gene-gene interactions with antipsychotic treatment response in patients with schizophrenia.
Taheri N; Pirboveiri R; Sayyah M; Bijanzadeh M; Ghandil P
BMC Psychiatry; 2023 Oct; 23(1):781. PubMed ID: 37880658
[TBL] [Abstract][Full Text] [Related]
38. Genetic combination risk for schizophrenia.
Oishi K; Niitsu T; Kanahara N; Hashimoto T; Komatsu H; Sasaki T; Takase M; Sato Y; Iyo M
Schizophr Res; 2020 Jan; 215():473-474. PubMed ID: 31477374
[No Abstract] [Full Text] [Related]
39. Association between DRD2 (rs1799732 and rs1801028) and ANKK1 (rs1800497) polymorphisms and schizophrenia: a meta-analysis.
Yao J; Pan YQ; Ding M; Pang H; Wang BJ
Am J Med Genet B Neuropsychiatr Genet; 2015 Jan; 168B(1):1-13. PubMed ID: 25504812
[TBL] [Abstract][Full Text] [Related]
40. Genetic risks of schizophrenia identified in a matched case-control study.
Oishi K; Niitsu T; Kanahara N; Sato Y; Iwayama Y; Toyota T; Hashimoto T; Sasaki T; Takase M; Shiina A; Yoshikawa T; Iyo M
Eur Arch Psychiatry Clin Neurosci; 2021 Jun; 271(4):775-781. PubMed ID: 32623490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
